Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...

MSD announced the data just days after Gilead also touted success with a once-daily antiretroviral therapy (ART).

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

"It's repulsive to have been born a woman. If I were a man, they might have beaten me and walked away - they wouldn't have ...

As of 2024, over 40 million people in the world are diagnosed with human immunodeficiency virus (HIV)-a chronic, life-threatening infection that remains one of the leading global causes of death.

Tatenda Makoni is a Zimbabwean-born medical student at the Medical College of Wisconsin whose work bridges global health and ...

From medical neglect to suicide, the lack of information on jail deaths can allow the same deadly problems to lead to more ...

The report card is mixed. Thanks to the efforts of community-based health organizations, researchers and healthcare providers ...